Healthcare101

 The Global Bone Growth Stimulator Market in terms of revenue was estimated to be worth $1.4 billion in 2022 and is poised to reach $1.8 billion by 2027, growing at a CAGR of 5.9% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The growing demand for bone growth stimulators in spinal fusion surgeries, delayed union and nonunion bone fracture applications, and the increasing demand for bone growth stimulator devices are the major driving factors of this market. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=82341383 Market Dynamics Market Drivers Growing patient preference for noninvasive and minimally invasive surgical treatments Increasing target patient population Rising number of sports and accident-related orthopedic ...

  The   Bone Growth Stimulator Market   is projected to reach USD 1.8 billion by 2027 from an estimated USD 1.4 billion in 2022, at a CAGR of 5.9%. The growth of the global bone growth stimulators market can be attributed to factors such as increasing research activities for the development of novel bone growth stimulators devices, growing demand for bone growth stimulators in spinal fusion surgeries, delayed union and nonunion bone fractures, oral and maxillofacial surgeries applications; the rising number of bone-related diseases. Key Market Players: Orthofix Medical Inc. (US), Enovis (DJO Finance, LLC) (US), ZimVie (US), Bioventus LLC (US), Medtronic plc (Ireland), Stryker (US), DePuy Synthes (US), Arthrex, Inc. (US), Isto Biologics (US Terumo Corporation (Japan), Ember Therapeutics, Inc. (US), Ossatec Benelux Ltd. (Netherlands), Altis Biologics (Pty) Ltd. (South Africa), Regen Lab SA (Switzerland), ITO Co., Ltd. (Japan), Elizur Corporation (US), BTT Health GmbH (Germa...